S. Lantuejoul

发表

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.

L. Bubendorf, F. Herth, R. Rintoul, 2012, Lung cancer.

Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.

J. Pignon, E. Brambilla, S. Lantuejoul, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early detection of lung cancer: role of biomarkers

S. Lantuejoul, G. Ferretti, S. Lantuejoul, 2003, European Respiratory Journal.

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions

N. Girard, J. Blay, F. Galateau-Sallé, 2019, EBioMedicine.

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

K. Cibulskis, J. Shendure, G. Getz, 2012, Nature Genetics.

A Genomics-Based Classification of Human Lung Tumors

G. Getz, S. Carter, D. Hayes, 2013, Science Translational Medicine.

Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers

Elisabeth Brambilla, Sophie Rousseaux, Aurélien de Reyniès, 2013, Science Translational Medicine.

Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice

A. Saqi, A. Moreira, S. Lantuejoul, 2022, JTO clinical and research reports.

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.

Gwénaël Le Teuff, Elisabeth Brambilla, Lesley Seymour, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Jean Mosser, Franck Morin, Gérard Zalcman, 2016, The Lancet.

Intermittent hypoxia induces early functional cardiovascular remodeling in mice.

S. Lantuejoul, C. Guillermet, P. Lévy, 2008, American journal of respiratory and critical care medicine.

Differentiating pre- and minimally invasive from invasive adenocarcinoma using CT-features in persistent pulmonary part-solid nodules in Caucasian patients.

Alexandre Moreau-Gaudry, Maud Medici, Mathieu Lederlin, 2015, European journal of radiology.

Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth

S. Lantuejoul, M. Pellerano, M. Morris, 2020, Theranostics.

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi‐Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center

N. Le Stang, N. Girard, A. Nicholson, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.

S. Armato, P. Courtiol, N. Girard, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas

N. Le Stang, F. Galateau-Sallé, M. Beasley, 2019, Modern Pathology.

PD-L1 Testing for Immune Checkpoint Inhibitors in Mesothelioma: For Want of Anything Better?

N. Le Stang, F. Galateau-Sallé, S. Lantuejoul, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.

S. Lantuejoul, D. Planchard, O. Molinier, 2019, The Lancet. Oncology.

Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.

T. Molina, S. Lantuejoul, P. Bahadoran, 2011, American journal of clinical pathology.

Imaging of tumors of the trachea and central bronchi.

G. Ferretti, S. Lantuejoul, C. Righini, 2010, Thoracic surgery clinics.

Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing

G. Ferretti, E. Brambilla, S. Lantuejoul, 2004, European Respiratory Journal.

Chemoprevention of lung cancer.

S. Lantuejoul, F. André, J. Soria, 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting: PD-L1 test harmonization studies

S. Lantuejoul, J. Adam, F. Damiola, 2020, Translational lung cancer research.

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade

S. Lantuejoul, A. Viari, C. Caux, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

The E-cadherin–β-catenin complex and its implication in lung cancer progression and prognosis

E. Brambilla, S. Lantuejoul, B. Eymin, 2005 .

MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

N. Girard, S. Lantuejoul, J. Mazières, 2017, Oncotarget.

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

C. Rudin, P. V. Van Schil, D. de Ruysscher, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI.

S. Lantuejoul, B. Eymin, S. Gazzéri, 2018, Cancer letters.

Usual interstitial pneumonia end-stage features from explants with radiologic and pathological correlations.

G. Ferretti, S. Lantuejoul, V. Cottin, 2015, Annals of diagnostic pathology.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1996, The American journal of pathology.

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours

E. Brambilla, S. Lantuejoul, J. Soria, 2004, British Journal of Cancer.

Primary lung adenocarcinoma: characteristics by smoking habit and sex

E. Brambilla, S. Lantuejoul, J. Timsit, 2011, European Respiratory Journal.

Wholistic approach: Transcriptomic analysis and beyond using archival material for molecular diagnosis

J. Blay, S. Lantuejoul, F. Tirode, 2022, Genes, chromosomes & cancer.

Drug-induced aortic valve stenosis: An under recognized entity.

M. Copin, S. Lantuejoul, L. Guillou, 2016, International journal of cardiology.

Benfluorex: An active toxin for the development of aortic valve stenosis.

S. Lantuejoul, C. Tribouilloy, O. Chavanon, 2015, International journal of cardiology.

[Why proposing a new histomolecular classification of lung cancers in 2015?].

S. Lantuejoul, 2016, Annales de pathologie.

Imaging of tumors of the trachea and central bronchi.

G. Ferretti, S. Lantuejoul, C. Righini, 2009, Radiologic clinics of North America.

Pulmonary involvement by Niemann–Pick disease. A report of six cases

A. Nicholson, E. Brambilla, S. Lantuejoul, 2006, Histopathology.

p53 in the Clinic: A Pathologist’s View

P. Varlet, Y. Allory, S. Lantuejoul, 2013 .

Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society.

A. Borczuk, M. Mino‐Kenudson, Y. Yatabe, 2016, Archives of Pathology & Laboratory Medicine.

Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.

E. Brambilla, S. Lantuejoul, M. Papotti, 2002, Human pathology.

Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.

E. Brambilla, S. Lantuejoul, M. Papotti, 2001, Human pathology.

Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis

G. Ferretti, E. Brambilla, S. Lantuejoul, 1997, Histopathology.

Histopathology of lung tumors

E. Brambilla, S. Lantuejoul, 2008 .

Reclassification of Neuroendocrine Tumors Improves the Separation of Carcinoids and the Prediction of Survival

M. Krasnik, E. Brambilla, S. Lantuejoul, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

34βE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma

E. Brambilla, S. Lantuejoul, M. Papotti, 2003 .

Divergent differentiation in neuroendocrine lung tumors.

E. Brambilla, S. Lantuejoul, N. Sturm, 2000, Seminars in diagnostic pathology.

What Is a Neuroendocrine Tumor

E. Brambilla, S. Lantuejoul, 2000 .

Placental transmogrification of the lung: CT-pathologic correlation of a rare pulmonary nodule.

G. Ferretti, S. Lantuejoul, P. Brichon, 2004, AJR. American journal of roentgenology.

CT-guided Biopsy of Nonresolving Focal Air Space Consolidation

G. Ferretti, S. Lantuejoul, C. Brambilla, 2008, Journal of thoracic imaging.

Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.

N. Girard, T. Molina, A. Marx, 2015, Pathology, research and practice.

Mucinous Cells in Type 1 Pulmonary Congenital Cystic Adenomatoid Malformation as Mucinous Bronchioloalveolar Carcinoma Precursors

A. Nicholson, E. Brambilla, P. Goldstraw, 2007, The American journal of surgical pathology.

Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival

B. Milleron, S. Lantuejoul, G. Zalcman, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[New classification of pulmonary cancer: application to small size biopsy sampling].

E. Brambilla, S. Lantuejoul, 2010, Annales de pathologie.

O-127 IALT (International Adjuvant Lung Cancer Trial): Quality assessment and histopathological review according to the WHO 2004 classification and assessment of prognostic and predictive role of pathological criteria

E. Brambilla, S. Lantuejoul, H. Popper, 2005 .

E-cadherin-β-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis

E. Brambilla, S. Lantuejoul, H. Drabkin, 2004 .

Telomerase activation in adenocarcinoma–bronchioloalveolar carcinoma

E. Brambilla, S. Lantuejoul, 2006, European Respiratory Journal.

34BetaE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma.

E. Brambilla, S. Lantuejoul, M. Papotti, 2003, Histopathology.

c‐MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas

N. Girard, S. Lantuejoul, J. Mazières, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases

A. Nicholson, A. Borczuk, A. Warth, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Mutant Immunophenotype and Deregulation of p 53 Transcription Pathway ( Bc 12 , Bax , and Waft ) in Precursor Bronchial Lesions of Lung Cancer 1

E. Brambilla, S. Lantuejoul, C. Brambilla, 2005 .

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

Martin Vingron, Thomas Zander, Yupeng Cun, 2018, Nature Communications.

Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT.

C. Gulmann, S. Lantuejoul, E. Kay, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report.

C. Dooms, N. Girard, H. Gietema, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer.

S. Boyault, S. Lantuejoul, C. Caux, 2022, European journal of cancer.

Case report. Pulmonary involvement in Niemann-Pick disease subtype B: CT findings.

G. Ferretti, E. Brambilla, S. Lantuejoul, 1996, Journal of computer assisted tomography.

[Cavitating nodules in a 40-year-old non-smoking woman: a very particular tumour].

G. Ferretti, S. Lantuejoul, D. Moro-Sibilot, 2012, Revue des maladies respiratoires.

Metastases from bronchioloalveolar carcinomas associated with long‐standing type 1 congenital cystic adenomatoid malformations. A report of two cases

A. Nicholson, D. Hansell, G. Ferretti, 2006, Histopathology.

CT characteristics of resolving ground-glass opacities in a lung cancer screening programme.

G. Ferretti, S. Lantuejoul, J. Timsit, 2011, European journal of radiology.

[Non-solid and part-solid pulmonary nodules on CT scanning].

G. Ferretti, S. Lantuejoul, C. Brambilla, 2007, Revue des maladies respiratoires.

T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase‐9 via a C‐C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction

J. Vincent, Y. Castier, A. Didier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey.

N. Girard, D. de Ruysscher, S. Lantuejoul, 2022, Lung cancer.

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.

N. Girard, S. Lantuejoul, S. Novello, 2018, European journal of cancer.

Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis: A Clinicopathologic Study of 35 Cases

A. Nicholson, M. Sheppard, B. Corrin, 2006, The American journal of surgical pathology.

Erdheim-Chester disease: a primary macrophage cell disorder.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1998, American journal of respiratory and critical care medicine.

[2014 classification of lung carcinomas: latest entities and clinical implications. Case 6: Large cell neuroendocrine carcinoma combined].

S. Lantuejoul, 2013, Annales de pathologie.

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients.

S. Lantuejoul, C. Caux, P. Saintigny, 2022, European Journal of Cancer.

Statin-induced fibrotic nonspecific interstitial pneumonia

E. Brambilla, S. Lantuejoul, C. Brambilla, 2002, European Respiratory Journal.

[PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists].

N. Girard, F. Galateau-Sallé, S. Lantuejoul, 2018, Annales de pathologie.

Clinical prognostic indicators of high-grade pre-invasive bronchial lesions

E. Brambilla, S. Lantuejoul, C. Brambilla, 2004, European Respiratory Journal.

Predicting Response to Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Blockade in NSCLC-Is Multiplex Immunohistochemistry or Immunofluorescence the Answer?

M. Mino‐Kenudson, S. Lantuejoul, W. Cooper, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer

N. Le Stang, S. Lantuejoul, F. Penault-Llorca, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels.

E. Brambilla, S. Lantuejoul, B. Eymin, 2007, The Journal of pathology.

Molecular and Immune Biomarkers in Acute Respiratory Distress Syndrome: A Perspective From Members of the Pulmonary Pathology Society.

M. Mino‐Kenudson, M. Beasley, S. Lantuejoul, 2017, Archives of pathology & laboratory medicine.

The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition.

J. Pépin, S. Lantuejoul, F. Mach, 2011, American journal of respiratory and critical care medicine.

Placental transmogrification of the lung: clinicopathologic, immunohistochemical and molecular study of two cases, with particular emphasis on the interstitial clear cells.

S. Lantuejoul, G. Rossi, M. Paci, 2004, Human Pathology.

Cardiovascular consequences of OSA: Which markers, where and when measuring them?

P. Lavie, J. Stradling, S. Lantuejoul, 2012 .

Lobular distributed ground-glass opacification due to metastatic cardiac angiosarcoma: High resolution CT, MIP, and pathologic findings

G. Ferretti, S. Lantuejoul, C. Brambilla, 2007 .

Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases

A. Nicholson, S. Lantuejoul, C. Farver, 2020, Histopathology.

Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma.

S. Lantuejoul, S. Lebecque, C. Blanquart, 2019, Cancer letters.

Atypical primary epithelioid hemangioendothelioma of the heart.

E. Brambilla, S. Lantuejoul, L. Guillou, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Druggable Growth Dependencies and Tumor Evolution Analysis in Patient-Derived Organoids of Neuroendocrine Cancer

H. Clevers, S. Lantuejoul, J. G. van den Berg, 2022, bioRxiv.

Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma

G. Ferretti, E. Brambilla, S. Lantuejoul, 2007, European Respiratory Journal.

The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.

A. Nicholson, A. Borczuk, G. Scagliotti, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study.

N. Girard, T. Molina, A. Marx, 2020, European journal of cancer.

[Targeting insulin-like growth factors in the treatment of cancer].

S. Lantuejoul, D. Moro-Sibilot, M. Coudurier, 2010, Revue des maladies respiratoires.

SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses

J. Blay, S. Lantuejoul, F. Tirode, 2019, The American journal of surgical pathology.

Crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC). Preliminary results of the ACSé phase II trial.

G. Ferretti, S. Lantuejoul, G. Vassal, 2015 .

The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

N. Le Stang, A. Borczuk, I. Wistuba, 2022, Journal of Thoracic Oncology.

Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.

S. Lantuejoul, O. Molinier, J. Mazières, 2019, Clinical lung cancer.

Twenty‐two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson’s disease

S. Lantuejoul, C. Robert, D. Leroux, 2009, Pigment cell & melanoma research.

Course and prognosis of basaloid squamous cell carcinoma of the head and neck: a case-control study of 62 patients.

E. Brambilla, S. Lantuejoul, M. Bolla, 2008, European journal of cancer.

Mucinous cystadenoma of the lung

E. Brambilla, S. Lantuejoul, C. Brambilla, 1995, Cancer.

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

N. Girard, S. Lantuejoul, S. Novello, 2019, European journal of cancer.

MA25.02 Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts

N. Girard, H. Gietema, G. Scagliotti, 2018, Journal of Thoracic Oncology.

MA25.01 EORTC Lung Cancer Group Survey to Define Synchronous Oligometastatic Disease in NSCLC

N. Girard, A. Dingemans, S. Lantuejoul, 2018, Journal of Thoracic Oncology.

Cytoplasmic cellular structures control permeability of outer mitochondrial membrane for ADP and oxidative phosphorylation in rat liver cells.

M. Rigoulet, X. Leverve, S. Lantuejoul, 1995, Biochemical and biophysical research communications.

[Pleural granulocytic sarcoma. Apropos of a case and review of the literature].

E. Brambilla, S. Lantuejoul, C. Brambilla, 1998, Revue des maladies respiratoires.

NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas.

E. Brambilla, S. Lantuejoul, C. Brambilla, 2000, Human pathology.

Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.

E. Brambilla, S. Lantuejoul, R. Michalides, 1998, The American journal of surgical pathology.

[Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].

S. Lantuejoul, M. Leccia, J. Béani, 2006, Annales de dermatologie et de venereologie.

TUNEL Apoptotic Cell Detection in Tissue Sections: Critical Evaluation and Improvement

E. Brambilla, S. Lantuejoul, C. Guillermet, 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society.

M. Mino‐Kenudson, Y. Yatabe, M. Beasley, 2017, Archives of pathology & laboratory medicine.

Pleuro-pulmonary Solitary Fibrous Tumors: A Clinicopathologic, Immunohistochemical, and Molecular Study of 88 Cases Confirming the Prognostic Value of de Perrot Staging System and p53 Expression, and Evaluating the Role of c-kit, BRAF, PDGFRs (α/β), c-met, and EGFR

S. Lantuejoul, G. Rossi, B. Murer, 2008, The American journal of surgical pathology.

Pathology and immunohistochemistry of lung cancer

E. Brambilla, S. Lantuejoul, 2009 .

Chemoprevention of lung cancer.

Edward S. Kim, W. Hong, S. Lantuejoul, 2003, The Lancet. Oncology.

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.

Akihiko Yoshida, Mari Mino-Kenudson, Arne Warth, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of Thoracic Oncology.

New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts

N. Girard, S. Lantuejoul, F. Damiola, 2020, Translational lung cancer research.

PD-L1 Testing for Lung Cancer in 2019: Perspective from the IASLC Pathology Committee.

N. Girard, A. Nicholson, A. Borczuk, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Aurélie A G Gabriel, N. Le Stang, N. Girard, 2019, Nature Communications.

New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management

S. Lantuejoul, E. Speel, L. Fernandez-Cuesta, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.

A. Borczuk, M. Mino‐Kenudson, Y. Yatabe, 2016, Archives of pathology & laboratory medicine.

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

N. Girard, J. Blay, F. Galateau-Sallé, 2015, Nature Genetics.

On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas.

E. Brambilla, S. Lantuejoul, J. Sabourin, 2014, Lung cancer.

A Recombinant Fungal Lectin for Labeling Truncated Glycans on Human Cancer Cells

Jean-Luc Coll, Amandine Hurbin, Anne Imberty, 2015, PloS one.

Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer

E. Brambilla, S. Lantuejoul, C. Brambilla, 2005, European Respiratory Journal.

CD74-NRG1 fusions in lung adenocarcinoma.

I. Petersen, S. Haas, M. Vingron, 2014, Cancer discovery.

The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.

W. Travis, E. Brambilla, M. Beasley, 2003, Human pathology.

Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Alterations of Rb Pathway ( Rbp 16 INK 4-Cyclin D 1 ) in Preinvasive Bronchial Lesions 1

E. Brambilla, S. Lantuejoul, C. Brambilla, 1999 .

p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

M. Mino‐Kenudson, S. Monaco, M. Beasley, 2017, Archives of pathology & laboratory medicine.

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Gwénaël Le Teuff, Lesley Seymour, Ming-Sound Tsao, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Elisabeth Brambilla, David Sidransky, Julian Carretero, 2015, Cancer research.

Inactivation in Lung Squamous Cell Carcinomas Impairs STAT 3 and Promotes Malignant Invasion

E. Brambilla, S. Lantuejoul, S. Verdura, 2015 .

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of Thoracic Oncology.

[Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers].

S. Lantuejoul, J. Adam, A. Cazes, 2017, Annales de pathologie.

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.

A. Borczuk, M. Mino‐Kenudson, Y. Yatabe, 2016, Archives of pathology & laboratory medicine.

[PD-L1 expression: An emerging biomarker in non-small cell lung cancer].

S. Lantuejoul, D. Planchard, J. Adam, 2016, Annales de pathologie.

Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions.

E. Brambilla, S. Lantuejoul, F. André, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Telomerase expression in lung preneoplasia and neoplasia

E. Brambilla, S. Lantuejoul, J. Soria, 2007, International journal of cancer.

Pulmonary preneoplasia – sequential molecular carcinogenetic events

E. Brambilla, S. Lantuejoul, C. Salon, 2009, Histopathology.

Disentangling heterogeneity of Malignant Pleural Mesothelioma through deep integrative omics analyses

Erik N. Bergstrom, P. Courtiol, C. Maussion, 2021, bioRxiv.

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

I. Petersen, D. Hayes, M. Wilkerson, 2018, Nature Communications.

[New WHO classification of lung adenocarcinoma and preneoplasia].

W. Travis, E. Brambilla, S. Lantuejoul, 2016, Annales de pathologie.

Biology of Human Tumors Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Speci fi c Molecular Entity

P. Hainaut, E. Brambilla, S. Lantuejoul, 2014 .

Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.

E. Brambilla, S. Lantuejoul, C. Brambilla, 2010, Lung cancer.

The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer.

Edward S. Kim, M. Tsuboi, G. Scagliotti, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.

N. Le Stang, F. Galateau-Sallé, G. Ferretti, 2016, Human pathology.

PL04a.04: Multicentric French Harmonization Study for PD-L1 IHC Testing in NSCLC

S. Lantuejoul, F. Penault-Llorca, J. Adam, 2017 .

Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma

E. Brambilla, S. Lantuejoul, B. Eymin, 2012, PloS one.

Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

I. Wistuba, M. Mino‐Kenudson, F. Hirsch, 2022 .

Validation of the QR1 Antibody for the Evaluation of PD-L1 Expression in Non–Small Cell Lung Adenocarcinomas

S. Lantuejoul, C. Mascaux, I. Rouquette, 2020, Applied immunohistochemistry & molecular morphology : AIMM.

Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma.

S. Lantuejoul, J. Adam, D. Damotte, 2019, Journal of thoracic disease.

PD‐L1 Immunohistochemistry Comparability Study in Real‐Life Clinical Samples: Results of Blueprint Phase 2 Project

Hui Yu, Keith M. Kerr, Ignacio Wistuba, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

A. Borczuk, M. Mino‐Kenudson, Y. Yatabe, 2017, Archives of pathology & laboratory medicine.

P2.09-17 Real-World Concordance Across Pathologists for PD-L1 Scoring in Non-Small Cell Lung Cancer: Results from a Large Nationwide Initiative

M. Copin, S. Lantuejoul, F. Penault-Llorca, 2019, Journal of Thoracic Oncology.

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

A. Nicholson, A. Borczuk, L. Chirieac, 2018, Journal of Thoracic Oncology.

CT-texture analysis of subsolid nodules for differentiating invasive from in-situ and minimally invasive lung adenocarcinoma subtypes.

F. Laurent, M. Lederlin, G. Ferretti, 2018, Diagnostic and interventional imaging.

Fibromyxoma of the retropharyngeal space: MR appearance with pathologic correlation.

J. Le Bas, G. Ferretti, S. Lantuejoul, 1998, AJNR. American journal of neuroradiology.

Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center.

G. Wainrib, P. Courtiol, C. Maussion, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer.

N. Le Stang, A. Nicholson, A. Borczuk, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study

E. Brambilla, S. Lantuejoul, F. de Fraipont, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

T. Molina, J. Jais, S. Lantuejoul, 2010, Clinical Cancer Research.

Inter-observer Reliability of Programmed Cell Death Ligand-1 Scoring Using the VENTANA PD-L1 (SP263) Assay in Non-Small Cell Lung Cancer.

A. Nicholson, K. Kerr, E. Thunnissen, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Defining morphologic features of invasion in pulmonary non-mucinous adenocarcinoma with lepidic growth - A proposal by the IASLC Pathology Committee.

A. Nicholson, A. Borczuk, W. Travis, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC

G. Ferretti, S. Lantuejoul, D. Moro-Sibilot, 2015, Targeted Oncology.

French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas

N. Le Stang, F. Galateau-Sallé, S. Lantuejoul, 2015, European Respiratory Journal.

Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer

J. Cigudosa, E. Brambilla, S. Lantuejoul, 2013, International journal of cancer.

Why technical aspects rather than biology explain cellular heterogeneity in ALK-positive non-small cell lung cancer.

S. Lantuejoul, A. Mcleer-Florin, 2012, Journal of thoracic disease.

Fishing for ALK with immunohistochemistry may predict response to crizotinib

S. Lantuejoul, G. Rossi, M. Tiseo, 2013 .

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

M. Mino‐Kenudson, Y. Yatabe, M. Beasley, 2016, Archives of pathology & laboratory medicine.

Pulmonary Nodules with the CT Halo Sign

S. Lantuejoul, C. Brambilla, M. Coulomb, 2002, Respiration.

Altered pattern of Cul‐1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels

E. Brambilla, S. Lantuejoul, B. Eymin, 2007 .

Personalized chemotherapy of lung cancer: What the radiologist should know.

G. Ferretti, S. Lantuejoul, D. Moro-Sibilot, 2016, Diagnostic and interventional imaging.

Telomere Shortening and Telomerase Reverse Transcriptase Expression in Preinvasive Bronchial Lesions

E. Brambilla, S. Lantuejoul, J. Soria, 2005, Clinical Cancer Research.

Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.

E. Brambilla, S. Lantuejoul, C. Brambilla, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Inflammasome-independent NLRP3 function enforces ATM activity in response to genotoxic stress

S. Lantuejoul, B. Bartosch, Y. Couté, 2023, Life Science Alliance.

NLRP3 controls ATM activation in response to DNA damage

S. Lantuejoul, B. Bartosch, Y. Couté, 2020, bioRxiv.

Telomere Maintenance and DNA Damage Responses during Lung Carcinogenesis

E. Brambilla, S. Lantuejoul, J. Soria, 2010, Clinical Cancer Research.

ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.

P. Hainaut, G. Ferretti, E. Brambilla, 2018, Lung cancer.

Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer

E. Brambilla, S. Lantuejoul, B. Eymin, 2008, Clinical Cancer Research.

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

J. Blay, F. Ducray, S. Lantuejoul, 2021, Medical Oncology.

Significance of TP53 mutations as predictive markers of adjuvant cisplatin‐based chemotherapy in completely resected non‐small‐cell lung cancer

P. Hainaut, E. Brambilla, S. Lantuejoul, 2014, Molecular oncology.

Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis

E. Brambilla, S. Lantuejoul, J. Timsit, 2008, European Respiratory Journal.

[Thoracic neuroendocrine tumors].

E. Brambilla, S. Lantuejoul, 2005, Annales de pathologie.

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.

J. Blay, S. Boyault, S. Lantuejoul, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis

N. Le Stang, S. Lantuejoul, S. Lebecque, 2018, Cell Death & Disease.

Percutaneous CT-guided biopsy of lytic bone lesions in patients clinically suspected of lung cancer: Diagnostic performances for pathological diagnosis and molecular testing.

G. Ferretti, S. Lantuejoul, D. Moro-Sibilot, 2019, Lung cancer.

Editor's Note: Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer

E. Brambilla, S. Lantuejoul, B. Eymin, 2020, Clinical Cancer Research.

Multiphoton microscopy as a diagnostic tool for pathological analysis of sentinel lymph nodes

J. Lemiere, J. Douady, F. Estève, 2009, BiOS.

[Pulmonary inflammatory pseudotumor complicating the course of a community-acquired pneumopathy. A deceptive radio-clinical presentation].

E. Brambilla, S. Lantuejoul, C. Brambilla, 1997, Revue des maladies respiratoires.

Giant intracardiac neoplasic thrombus of a large cell neuroendocrine carcinoma of the lung.

S. Lantuejoul, P. Brichon, S. Stoica, 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Wegener Granulomatosis Revealed by Pleural Effusion

G. Ferretti, S. Lantuejoul, S. Diab, 2010, Case reports in medicine.

Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC

S. Lantuejoul, M. Richard, F. de Fraipont, 2011, Journal of experimental & clinical cancer research : CR.

Dramatic improvement in survival after lung transplantation over time: a single center experience.

E. Brambilla, S. Lantuejoul, P. Chaffanjon, 2009, Transplantation proceedings.

Diagnosis of cardiac tumors: contribution of non-invasive cardiac imaging in routine practice.

G. Ferretti, S. Lantuejoul, G. Vanzetto, 2012, International journal of cardiology.

Body mass index is related to the perception of exertional breathlessness in patients presenting with dyspnoea of unknown origin

G. Ferretti, S. Lantuejoul, G. Vanzetto, 2012 .

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

P. Courtiol, C. Maussion, N. Le Stang, 2023, Nature Genetics.

Morphological analysis of circulating tumour cells in patients undergoing surgery for non‐small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method

T. Molina, J. Jais, C. Marquette, 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

Tumor Mutation Burden: Promises and Challenges A Perspective from the IASLC Pathology Committee.

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cigarette smoking, preinvasive bronchial lesions, and autofluorescence bronchoscopy.

E. Brambilla, S. Lantuejoul, C. Brambilla, 2002, Chest.

Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines

Elisabeth Brambilla, E. Brambilla, S. Lantuejoul, 2003, The Journal of pathology.

Multicenter harmonization study of pan-Trk immunohistochemistry for the detection of NTRK3 fusions.

N. Le Stang, A. Vincent-Salomon, S. Lantuejoul, 2023, Modern Pathology.

Prognostic biomarkers in non-small-cell lung carcinoma

E. Brambilla, S. Lantuejoul, 2006 .

A Grading system for invasive pulmonary adenocarcinoma: a proposal from the IASLC pathology committee.

A. Nicholson, A. Borczuk, I. Wistuba, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management

B. Souweine, S. Lantuejoul, V. Leray, 2015, Intensive Care Medicine.

High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.

N. Girard, S. Lantuejoul, J. Mazières, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.

N. Girard, E. Letouzé, S. Lantuejoul, 2022, Lung cancer.

Nonsolid and part-solid pulmonary nodules

G. Ferretti, S. Lantuejoul, C. Brambilla, 2009 .

P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer

A. Nicholson, A. Borczuk, Guoan Chen, 2019, Journal of Thoracic Oncology.

Chlorine gas induced acute lung injury in isolated rabbit lung.

M. Corboz, S. Lantuejoul, G. Benchetrit, 1997, The European respiratory journal.

Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens

L. Bubendorf, E. Thunnissen, S. Lantuejoul, 2017, European Respiratory Review.

Pathology and molecular biology of lung cancer

S. Lantuejoul, V. Tischler, L. Mescam-Mancini, 2013 .

[What's new in the 2004 WHO classification of the lung tumors?].

E. Brambilla, S. Lantuejoul, 2008, Revue de pneumologie clinique.

An “Anaplastic” Kaposi's Sarcoma Mimicking a Stewart-Treves Syndrome. A Case Report and a Review of Literature

S. Lantuejoul, P. Morand, M. Leccia, 2008, The American Journal of dermatopathology.

Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: influence of ATS/ERS/IASLC guidelines.

G. Ferretti, E. Brambilla, S. Lantuejoul, 2013, Lung cancer.

Impact of Molecular Pathology on the Clinical Management of Lung Cancer

E. Brambilla, S. Lantuejoul, C. Brambilla, 2005, Respiration.

Course and prognosis of basaloid squamous cell carcinoma (BSCC) of the head and neck: A case-control study of 62 patients

E. Brambilla, S. Lantuejoul, M. Bolla, 2008 .

Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective from the IASLC Pathology Committee.

I. Wistuba, M. Mino‐Kenudson, F. Hirsch, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis

N. Le Stang, S. Lantuejoul, S. Lebecque, 2018, Cell Death & Disease.

Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity

P. Hainaut, E. Brambilla, S. Lantuejoul, 2014, Clinical Cancer Research.

Translational Relevance

Sophie, Saadi, P. Hainaut, 2022 .

Small-Cell Lung Cancer Transformation as a Mechanism of Resistance to Pralsetinib in RET-Rearranged Lung Adenocarcinoma: A Case Report.

S. Lantuejoul, A. Bouhamama, T. Franceschi, 2022, Clinical lung cancer.

Fishing for ALK with immunohistochemistry may predict response to crizotinib.

S. Lantuejoul, G. Rossi, M. Tiseo, 2013, Tumori.

E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis.

E. Brambilla, S. Lantuejoul, H. Drabkin, 2004, Human pathology.

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.

J. Blay, S. Boyault, S. Lantuejoul, 2019 .

[2014 classification of lung carcinomas: latest entities and clinical implications. Case 5: Lymph node metastasis of an atypical carcinoid].

S. Lantuejoul, 2013, Annales de pathologie.

[Aspergillus flavus endocarditis on a native valve].

S. Lantuejoul, M. Laramas, J. Bagueta, 2004, Archives des maladies du coeur et des vaisseaux.

Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors

S. Lantuejoul, C. Caux, P. Saintigny, 2022, Data in brief.

Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung

A. Nicholson, A. Borczuk, A. Warth, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chest pains complicating an artificial therapeutic pneumothorax.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1997, European Respiratory Journal.

[Rythmic-pathology: the French national pathology network for thymic epithelial tumours].

N. Girard, T. Molina, A. Marx, 2014, Annales de pathologie.

Multiple microthrombi on a papillary fibroelastoma of the aortic valve.

S. Lantuejoul, O. Chavanon, A. Boignard, 2012, The Annals of thoracic surgery.

An uncommon cause of renovascular hypertension.

S. Lantuejoul, O. Chavanon, F. Thony, 2012, The Canadian journal of cardiology.

Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations.

G. Ferretti, S. Lantuejoul, S. Khochbin, 2021, Lung cancer.

Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.

E. Brambilla, S. Lantuejoul, B. Vandenbunder, 1996, Laboratory investigation; a journal of technical methods and pathology.

c‐MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas

N. Girard, S. Lantuejoul, J. Mazières, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung adenocarcinomas: correlation of computed tomography and pathology findings.

G. Ferretti, E. Brambilla, S. Lantuejoul, 2016, Diagnostic and interventional imaging.

PD2-3-4: Prognostic and predictive value of apoptosis related factors Fas, FasL and survivin in non small cell lung carcinoma patients enrolled in the IALT Trial

E. Brambilla, S. Lantuejoul, H. Popper, 2007 .

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

A. Nicholson, A. Borczuk, I. Wistuba, 2020 .

Precision medicine at its best: Prolonged survival in a child presenting a secondary mesothelioma treated with crizotinib

S. Lantuejoul, B. Geoerger, G. Vassal, 2020, Pediatric blood & cancer.

Second/third-line nivolumab vs nivo plus ipilimumab in malignant pleural mesothelioma: Long-term results of IFCT-1501 MAPS2 phase IIR trial with a focus on hyperprogression (HPD)

S. Lantuejoul, D. Planchard, O. Molinier, 2019, Annals of Oncology.

Compliance to regional recommendations for molecular analyses and management of advanced lung cancer patients.

S. Lantuejoul, I. Ray-Coquard, F. de Fraipont, 2019, Future oncology.